MD3803G2 - Metodă de tratament al hiperchineziilor la copii - Google Patents

Metodă de tratament al hiperchineziilor la copii

Info

Publication number
MD3803G2
MD3803G2 MDA20080096A MD20080096A MD3803G2 MD 3803 G2 MD3803 G2 MD 3803G2 MD A20080096 A MDA20080096 A MD A20080096A MD 20080096 A MD20080096 A MD 20080096A MD 3803 G2 MD3803 G2 MD 3803G2
Authority
MD
Moldova
Prior art keywords
compositum
months
day during
homaccord
pill
Prior art date
Application number
MDA20080096A
Other languages
English (en)
Russian (ru)
Other versions
MD3803F1 (ro
Inventor
Светлана ХАДЖИУ
Original Assignee
Светлана ХАДЖИУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Светлана ХАДЖИУ filed Critical Светлана ХАДЖИУ
Priority to MDA20080096A priority Critical patent/MD3803G2/ro
Publication of MD3803F1 publication Critical patent/MD3803F1/ro
Publication of MD3803G2 publication Critical patent/MD3803G2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Invenţia se referă la medicină, în special la neurologie, pediatrie, reflexoterapie şi poate fi utilizată pentru tratamentul copiilor cu hiperchinezii.Metoda, conform invenţiei, constă în aceea că pacientului i se administrează per os preparatele Lymphomyosot, Berberis-Homaccord, Gelsemium-Homaccord câte 5…10 picături de 3 ori pe zi în decurs de 1…2 luni şi sublingual Nervoheel câte 1 pastilă de 3 ori pe zi timp de 1...3 luni, Spascupreel şi Spigelon câte 1 pastilă de 3 ori pe zi timp de 1...2 luni. Începând cu a doua săptămână de tratament se introduc subcutanat preparatele Cerebrum compositum N câte 2,2 ml, TraumeelS câte 2,2 ml,Placenta compositum câte 2,2 ml, Coenzyme compositum câte 2,2 ml, Ubichinon compositum câte 2,2 ml, de 1...2 ori pe săptămână în regiunea punctelor biologic active E 36, 40, 44; G 11, 14, 18; MC 6; RP 6, 9; C 5, 7; V 1, 6, 10, 11, 15, 60, 62, 63, 64; VB 1, 16, 20, 41; T 2, 3, 16, 17, 21, 22; IG 3; TR 23; P 3, 7 timp de 5 săptămâni, totodată în fiecare punct biologic activ se introduce un singur preparat medicamentos menţionat, iar fiecare preparat se introduce în 3…5 puncte.
MDA20080096A 2008-03-31 2008-03-31 Metodă de tratament al hiperchineziilor la copii MD3803G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080096A MD3803G2 (ro) 2008-03-31 2008-03-31 Metodă de tratament al hiperchineziilor la copii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080096A MD3803G2 (ro) 2008-03-31 2008-03-31 Metodă de tratament al hiperchineziilor la copii

Publications (2)

Publication Number Publication Date
MD3803F1 MD3803F1 (ro) 2009-01-31
MD3803G2 true MD3803G2 (ro) 2009-08-31

Family

ID=40347766

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080096A MD3803G2 (ro) 2008-03-31 2008-03-31 Metodă de tratament al hiperchineziilor la copii

Country Status (1)

Country Link
MD (1) MD3803G2 (ro)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD38Z5 (ro) * 2009-02-20 2010-02-28 Татьяна ГИДИРИМСКИЙ Metodă de corecţie a vederii la slab văzători
MD25Z (ro) * 2009-02-25 2010-02-28 Родика БЫЛБА Metodă de tratament al tulburărilor aparatului de acomodare
MD39Z5 (ro) * 2009-03-03 2010-02-28 Родика БЫЛБА Metodă de tratament al miopiei dobândite necomplicate progresive

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019174C1 (ru) * 1991-07-15 1994-09-15 Лобзин Владир Семенович Способ лечения гиперкинезов у детей
RU2092201C1 (ru) * 1994-04-06 1997-10-10 Российская медицинская академия последипломного образования Способ лечения тикозных гиперкинезов
RU2099079C1 (ru) * 1995-12-29 1997-12-20 Санкт-Петербургская государственная педиатрическая медицинская академия Средство для лечения тикозных гиперкинезов

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019174C1 (ru) * 1991-07-15 1994-09-15 Лобзин Владир Семенович Способ лечения гиперкинезов у детей
RU2092201C1 (ru) * 1994-04-06 1997-10-10 Российская медицинская академия последипломного образования Способ лечения тикозных гиперкинезов
RU2099079C1 (ru) * 1995-12-29 1997-12-20 Санкт-Петербургская государственная педиатрическая медицинская академия Средство для лечения тикозных гиперкинезов

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Острейко Т.Я. Клинические проявления и показатели нейромедиаторного обмена синдрома Туретта у детей. Автореферат *
Острейко Т.Я. Клинические проявления и показатели нейромедиаторного обмена синдрома Туретта у детей. Автореферат диссертации канд. мед. наук. Москва, 1992, с.16 *
Смирнов А.Ю. О применении метоклопрамида (церукала) при синдроме Туретта. Невропатология и психиатрия, N 8, 1989, с. 105- *
Смирнов А.Ю. О применении метоклопрамида (церукала) при синдроме Туретта. Невропатология и психиатрия, N 8, 1989, с. 105-108 *

Also Published As

Publication number Publication date
MD3803F1 (ro) 2009-01-31

Similar Documents

Publication Publication Date Title
ES2653615T3 (es) Pluralidad de dosis de LAG-3 recombinante para su uso en la provocación de una respuesta inmunitaria de monocitos
JP2016514132A5 (ro)
NZ630790A (en) Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
AR099078A2 (es) Un medicamento que comprende acetato de glatiramer
NZ608502A (en) Polypeptides that bind to human complement component c5
WO2016109823A8 (en) Treatment of pediatric growth hormone deficiency with human growth hormone analogues
RU2016149316A (ru) Лечение ревматоидного артрита
Librodo et al. Chronotherapeutic drug delivery
JOP20190019A1 (ar) تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
MD3803G2 (ro) Metodă de tratament al hiperchineziilor la copii
JP2016505050A5 (ro)
JP2013540734A5 (ro)
RU2015115398A (ru) N-ацетил-L-цистеин для применения в экстракорпоральном оплодотворении
MX2024007749A (es) Formulaciones clinicas de anticuerpos anti-tigit.
IL310909A (en) Dosing regimens associated with extended release paliperidone injectable formulations
JOP20170044B1 (ar) تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو
JP2019535830A5 (ro)
JP2018522881A5 (ro)
JP2018513849A (ja) 対象における全身性免疫応答を抑制または低減するための組成物および方法
Ananth et al. Benztropine psychosis
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
MX2012005497A (es) Tivozanib y temsirolimus en combinacion.
MD3906G2 (ro) Metodă de tratament al enurezisului nevrotic la copii
HK1244231A1 (zh) 使用hcg治疗慢性疼痛的方法和治疗
MD3940G2 (ro) Metodă de tratament al paraliziei plexului brahial

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees